🇺🇸 FDA

Drug profile · INN

pemetrexed sodium

PEMETREXED

approved
US status
approved
Patents linked
3
News articles
0

Quick answer

pemetrexed sodium (PEMETREXED) is an FDA-listed pharmaceutical active ingredient. Associated with Teva Pharma GmbH. Route of administration: injection. Current US regulatory status: approved.

Key facts

INN pemetrexed sodium
Brand PEMETREXED
Route INJECTION
Formulation INJECTABLE
Originator Teva Pharma GmbH

Related patents

Search patents →

  1. US 11612662

    Multi-arm polymeric prodrug conjugates of pemetrexed-based compounds

    Expires Mon Mar 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 10736969

    Multi-arm polymeric prodrug conjugates of pemetrexed-based compounds

    Expires Mon Aug 06 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 8952153

    One pot process for preparing pemetrexed disodium

    Expires Mon Feb 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is pemetrexed sodium?

pemetrexed sodium (PEMETREXED) is an FDA-listed pharmaceutical active ingredient. Associated with Teva Pharma GmbH. Route of administration: injection. Current US regulatory status: approved.

What is the brand name for pemetrexed sodium?

PEMETREXED is a marketed brand name for pemetrexed sodium. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of pemetrexed sodium?

pemetrexed sodium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.